Politics and Government Politics and Government
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ] - Thomas Matters
Mobileye: Too Far, Too Fast
[ Tue, Nov 26th 2024 ] - Phil Bruner
World News
[ Tue, Nov 26th 2024 ] - Phil Bruner
Alexandra Petri
[ Tue, Nov 26th 2024 ] - Aaron Neefham
Latest Crypto News
[ Tue, Nov 26th 2024 ] - Aaron Neefham
Europe News
[ Tue, Nov 26th 2024 ] - Michael Jones
New on Crave: December 2024
[ Tue, Nov 26th 2024 ] - Aaron Neefham
TechCrunch Newsletters
[ Tue, Nov 26th 2024 ] - Aaron Neefham
November 2024 Issue
[ Tue, Nov 26th 2024 ] - Brian Stokes
Trust Matters in Cabinet Picks
[ Tue, Nov 26th 2024 ] - Aaron Neefham
Middle East

Vivek Ramaswamy's crusade to change FDA could boost biotech, and himself


Published on 2024-11-26 11:20:49 - Brian Stokes, N@N
  Print publication without navigation

  • The co-leader of President-elect Donald Trump's initiative to cut government spending has a financial stake in the biotech firm he founded, which is developing experimental drugs.

The article from The Detroit News discusses Vivek Ramaswamy's campaign to reform the U.S. Food and Drug Administration (FDA), focusing on his critique of the agency's regulatory processes which he believes stifle innovation in the biotech sector. Ramaswamy, a former biotech entrepreneur and now a political figure, argues that the FDA's stringent approval processes delay the availability of potentially life-saving drugs, thereby affecting patient outcomes and the growth of the biotech industry. His proposed changes include streamlining drug approvals, reducing the regulatory burden, and potentially benefiting from these reforms himself, given his past involvement in the biotech industry. Critics, however, worry that his reforms might prioritize speed over safety, potentially endangering public health. Ramaswamy's push for FDA reform is part of a broader political strategy to appeal to voters by promising to cut bureaucratic red tape, which could also serve his personal financial interests if he re-enters the biotech field.

Read the Full Detroit News Article at [ https://www.detroitnews.com/story/news/politics/2024/11/25/vivek-ramaswamys-crusade-to-change-fda-could-boost-biotech-and-himself/76572406007/ ]